4.3 Article

Chromatin Redistribution of the DEK Oncoprotein Represses hTERT Transcription in Leukemias

Journal

NEOPLASIA
Volume 16, Issue 1, Pages 21-U48

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1593/neo.131658

Keywords

-

Categories

Funding

  1. Ligue Nationale Contre le Cancer (Comites de l'Ain et du Rhone)
  2. Fondation de France
  3. Association Laurette Fugain
  4. Association pour la Recherche sur le Cancer (ARC)
  5. Association Guillaume Espoir
  6. Agence Nationale pour la Recherche
  7. AMGEN
  8. Celgene
  9. Novartis
  10. Centre Leon Berard
  11. Hospices Civils de Lyon
  12. University Lyon I
  13. Centre National pour la Recherche Scientifique
  14. Institut National de la Sante et de la Recherche Medicale (INSERM)
  15. Societe Francaise d'Hematologie
  16. ARC
  17. Guillaume Espoir Association
  18. INSERM
  19. Hospices Civils de Lyon (AVIE-SAN CHRT program)
  20. Lyon I University

Ask authors/readers for more resources

Although numerous factors have been found to modulate hTERT transcription, the mechanism of its repression in certain leukemias remains unknown. We show here that DEK represses hTERT transcription through its enrichment on the hTERT promoter in cells from chronic and acute myeloid leukemias, chronic lymphocytic leukemia, but not acute lymphocytic leukemias where hTERT is overexpressed. We isolated DEK from the hTERT promoter incubated with nuclear extracts derived from fresh acute myelogenous leukemia (AML) cells and from cells expressing Tax, an hTERT repressor encoded by the human T cell leukemia virus type 1. In addition to the recruitment of DEK, the displacement of two potent known hTERT transactivators from the hTERT promoter characterized both AML cells and Tax-expressing cells. Reporter and chromatin immunoprecipitation assays permitted to map the region that supports the repressive effect of DEK on hTERT transcription, which was proportionate to the level of DEK-promoter association but not with the level of DEK expression. Besides hTERT repression, this context of chromatin redistribution of DEK was found to govern about 40% of overall transcriptional modifications, including those of cancer-prone genes. In conclusion, DEK emerges as an hTERT repressor shared by various leukemia subtypes and seems involved in the deregulation of numerous genes associated with leukemogenesis.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available